FDA's evaluation concluded that the criteria weighed against placement on the list, citing inadequate physicochemical characterization, immunogenicity concerns from impurities and aggregates, lack of clinical effectiveness data for any approved use, and absence of published human exposure data for the proposed subcutaneous and topical routes
Rather than simply suppressing inflammation like NSAIDs or cortisone, BPC-157 appears to modulate the inflammatory response
Oral signs and symptoms in patients with undiagnosed vitamin B12 deficiency
A single 10 mg vial provides 24 days of material at these doses
Some studies have shown that a single dose could act as a biological switch that activates healing processes that then continue for monthsan effect that could make it very difficult to catch
The investigators reported that oral AOD-9604 administration in rodent models produced measurable increases in fat oxidation and reductions in body fat, and that direct application of the compound to ex vivo human adipose tissue produced concentration-dependent increases in lipolysis [2]
